Abbott logo
  • Brands
  • Offerings
  • Solutions
  • Knowledge Center



PROFESSIONAL PROFILE


Q&A

HOW HAS YOUR PROFESSIONAL JOURNEY LED TO YOUR CURRENT ROLE WITHIN ABBOTT?

PETER RIVIERE: After earning my Bachelors’ degree in Molecular Biology, I started working in a laboratory and then transitioned into various positions selling scientific consumables and equipment. Here at Abbott, I’ve been fortunate to work in number of different roles – each of which has provided me with excellent opportunities to increase my knowledge of laboratory practices. What led me to Technical Solutions Design is my passion for learning and sharing my knowledge to help laboratories – and the people who work in them – become more successful. For me, there is no greater satisfaction than helping someone expand their capabilities – and then watching them share what they’ve learned with others.

ON AVERAGE, HOW MANY LABORATORY WORKFLOWS DO YOU OBSERVE ON AN ANNUAL BASIS AND HOW DOES THIS EXPOSURE SHAPE YOUR APPROACH TO FUTURE ENGAGEMENTS?

PETER RIVIERE: My team and I may do three or four end-to-end business mapping workflows throughout the year. But we’re constantly doing tube workflows and process mapping in order to exchange insights. We’re in labs all the time, observing, listening, and collaborating to help solve challenges and improve operational performance. This creates a remarkable opportunity for us to gather learnings from a wide range of lab profiles, each of which is facing unique challenges. That’s what Technical Solutions Design is really about – continuous learning. We leverage industry insights to create value for the next laboratory that we engage with.

WHAT MARKET DYNAMICS DO YOU SEE AS BEING THE MOST IMPACTFUL FOR THE LABORATORY – TODAY AND TOMORROW?

PETER RIVIERE: Australia is an extremely consolidated market. One dynamic that I see are cost pressures driving laboratories to increase operational efficiency by maximizing asset utilization. Laboratories are weighing potential solutions to understand how adaptable the solutions could be in the event that the lab needs to realign its business model to changing market conditions – Every little advantage helps.

I also see consolidation exerting pressure on large laboratories to look inwardly at processes not traditionally considered core testing. In response, labs are consolidating services like molecular testing and mass spectrometry into the core laboratory environment, while decentralizing higher volume testing back out to smaller satellite labs within their networks, releasing pressure on hub facilities. This raises complex logistical issues such as access to scientific expertise, harmonization of instruments across labs, distribution of testing volume, and transportation of samples.

WHAT SHOULD LABORATORIES BE THINKING ABOUT AND DOING TO BE BETTER PREPARED FOR THESE DYNAMICS TODAY – AND IN YEARS AHEAD?

PETER RIVIERE: I think it all comes down to really effective strategic planning. Gathering and communicating useful insights, especially about past, current, and future healthcare trends. The importance of critical thinking at every level cannot be overemphasized. And bring your partners into the process. As it’s been said, “None of us is as smart as all of us.”

THAT’S WHAT TECHNICAL SOLUTIONS DESIGN IS REALLY ABOUT – CONTINUOUS LEARNING. WE LEVERAGE INDUSTRY INSIGHTS TO CREATE VALUE FOR EACH LABORATORY THAT WE ENGAGE WITH.

SIGN UP FOR OUR NEWSLETTER

Sign up to receive the next edition of Healthcare Catalyst where we bring you the latest information, insights, ideas and innovative solutions to improve healthcare through laboratory medicine.

Already an Abbott subscriber? You'll receive new issues of Healthcare Catalyst automatically, no need to sign up.

LATEST ARTICLES

  • SEEING THE BIG PICTURE

    Health systems and laboratories around the world are facing consolidation and cost pressures. In this interview you’ll find insights on how to address these market dynamics through a holistic approach to continuous improvement. 

    Read More
  • THINKING IT THROUGH

    The COVID-19 pandemic has made it clearer than ever that future proofing your lab means being positioned to adapt to ever-changing market conditions. In this interview, you’ll find useful insights on building agility and flexibility into laboratory infrastructure and operating culture.

    Read More
  • SMART THINKING

    This article illuminates market dynamics that could impact your laboratory in the coming years – and offers advice on how to address them. The focus is on setting SMART goals and putting a metrics framework around continuous improvement.

    Read More
  • FUTURE PROOFING YOUR LAB

    Laboratorio Clínico Toledo (Lab Toledo) is the largest laboratory in the Caribbean. Take a look inside Lab Toledo's 'future proofing' initiative and discover how the laboratory maintains market leadership and pivoted to meet Puerto Rico's need for COVID-19 testing.

    Read More

© 2022 Abbott, Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the products or services of the company.

All Alinity hq, CELL-DYN Ruby, CELL-DYN Sapphire and CELL-DYN Emerald 22 AL are Class I laser products. ACCELERATOR a3600 is a Class II laser product.

The Alinity, ACCELERATOR and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin (blood, urine). Read the instructions in the system manuals and labeling and/or reagent instructions carefully.

ADD-137615-GBL-EN